NCT00004865View on ClinicalTrials.gov

Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 1999

Primary Completion Date

January 31, 2002

Conditions
Head and Neck Cancer
Interventions
BIOLOGICAL

cetuximab

DRUG

cisplatin

DRUG

fluorouracil

DRUG

paclitaxel

Trial Locations (3)

08103

Cooper Cancer Institute, Camden

08701

Kimball Medical Center, Lakewood

07740

Monmouth Medical Center, Long Branch

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Eli Lilly and Company

INDUSTRY

lead

Jonsson Comprehensive Cancer Center

OTHER